Defense Production and Active Pharmaceutical Ingredients Act

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 6895 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 6895 To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES December 22, 2023 Ms. Slotkin introduced the following bill; which was referred to the Committee on Armed Services _______________________________________________________________________ A BILL To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Defense Production and Active Pharmaceutical Ingredients Act''. SEC. 2. MODIFICATION OF SUPPORT FOR RESEARCH AND DEVELOPMENT OF BIOI…